Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy

Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy

Michael Newnham,1,2 Mark Quinn,1 Alice M Turner1,2 1Institute of Applied Health Research, University of Birmingham, Birmingham, UK; 2University Hospitals Birmingham, Birmingham, UKCorrespondence: Alice M Turner, Institute of Applied Health Research, University of Birmingham, Birmingham, UK, Email a....

Full description

Bibliographic Details
Main Authors: Newnham M, Quinn M, Turner AM
Format: Article
Language:English
Published: Dove Medical Press 2023-06-01
Series:International Journal of COPD
Subjects:
alpha 1 antitrypsin deficiency
chronic obstructive pulmonary disease
epidemiology
Online Access:https://www.dovepress.com/estimating-the-prevalence-of-aatd-patients-in-the-uk-to-identify-under-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/estimating-the-prevalence-of-aatd-patients-in-the-uk-to-identify-under-peer-reviewed-fulltext-article-COPD

Similar Items